These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 15793800)

  • 21. Preparation, characterization, and pharmacokinetics study of capsaicin via hydroxypropyl-beta-cyclodextrin encapsulation.
    Zhao Y; Sun C; Shi F; Firempong CK; Yu J; Xu X; Zhang W
    Pharm Biol; 2016; 54(1):130-8. PubMed ID: 25853954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of hydroxypropyl-beta-cyclodextrin-complexation and pH on solubility of camptothecin.
    Saetern AM; Nguyen NB; Bauer-Brandl A; Brandl M
    Int J Pharm; 2004 Oct; 284(1-2):61-8. PubMed ID: 15454297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inclusion complex of colchicine in hydroxypropyl-β-cyclodextrin tenders better solubility and improved pharmacokinetics.
    Chauhan R; Madan J; Kaushik D; Sardana S; Pandey RS; Sharma R
    Pharm Dev Technol; 2013; 18(2):313-22. PubMed ID: 21699389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs.
    Daniel-Mwambete K; Torrado S; Cuesta-Bandera C; Ponce-Gordo F; Torrado JJ
    Int J Pharm; 2004 Mar; 272(1-2):29-36. PubMed ID: 15019066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel formulation strategies for enhancing oral delivery of methoxyflavones in Kaempferia parviflora by SMEDDS or complexation with 2-hydroxypropyl-β-cyclodextrin.
    Mekjaruskul C; Yang YT; Leed MG; Sadgrove MP; Jay M; Sripanidkulchai B
    Int J Pharm; 2013 Mar; 445(1-2):1-11. PubMed ID: 23376503
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased shelf-life of fosphenytoin: solubilization of a degradant, phenytoin, through complexation with (SBE)7m-beta-CD.
    Narisawa S; Stella VJ
    J Pharm Sci; 1998 Aug; 87(8):926-30. PubMed ID: 9687335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicochemical profile of nimesulide. Exploring the interplay of lipophilicity, solubility and ionization.
    Dellis D; Giaginis C; Tsantili-Kakoulidou A
    J Pharm Biomed Anal; 2007 May; 44(1):57-62. PubMed ID: 17336024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
    Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
    Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preformulation studies of myricetin: a natural antioxidant flavonoid.
    Yao Y; Lin G; Xie Y; Ma P; Li G; Meng Q; Wu T
    Pharmazie; 2014 Jan; 69(1):19-26. PubMed ID: 24601218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solubilization of a naphthoquinone derivative by hydroxypropyl-beta-cyclodextrin (HP-beta-CD) and polyvinylpyrrolidone (PVP-K30). The influence of PVP-K30 and pH on solubilizing effect of HP-beta-CD.
    Granero G; de Bertorello MM; Longhi M
    Boll Chim Farm; 2002; 141(1):63-6. PubMed ID: 12064060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of parenteral formulation for a novel angiogenesis inhibitor, CKD-732 through complexation with hydroxypropyl-beta-cyclodextrin.
    Kim JH; Lee SK; Ki MH; Choi WK; Ahn SK; Shin HJ; Hong CI
    Int J Pharm; 2004 Mar; 272(1-2):79-89. PubMed ID: 15019071
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of preparation method on itraconazole oral solutions using cyclodextrins as complexing agents.
    Holvoet C; Vander Heyden Y; Plaizier-Vercammen J
    Pharmazie; 2007 Jul; 62(7):510-4. PubMed ID: 17718191
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pH and complexation on transdermal permeation of gliquidone.
    Sridevi S; Diwan PV
    Pharmazie; 2002 Sep; 57(9):632-4. PubMed ID: 12369452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Wang S; Ding Y; Yao Y
    Drug Dev Ind Pharm; 2009 Jul; 35(7):808-13. PubMed ID: 19337873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sertaconazole/hydroxypropyl-beta-cyclodextrin complexation: isothermal titration calorimetry and solubility approaches.
    Rodriguez-Perez AI; Rodriguez-Tenreiro C; Alvarez-Lorenzo C; Taboada P; Concheiro A; Torres-Labandeira JJ
    J Pharm Sci; 2006 Aug; 95(8):1751-62. PubMed ID: 16795015
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
    Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
    Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous determination of pKa and lipophilicity by gradient RP HPLC.
    Wiczling P; Kawczak P; Nasal A; Kaliszan R
    Anal Chem; 2006 Jan; 78(1):239-49. PubMed ID: 16383333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.